Business
Dario Secures Five New Employer Contracts Across Cardiometabolic Suite Including its Largest Employer to Date, Contributing to Annual Recurring Revenues Beginning Q3 2025
DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, today announced the launch of five new contracts with self-insured employers. All five programs went live during the second and third quarters of 2025 and feature Dario's full cardiometabolic suite, highlighting continued demand for integrated, multi-condition solutions.
About this update from Dariohealth Corp.
[{"type":"text","content":"New customer launches representing 107,000 lives covered reinforce Dario's B2B2C momentum and recurring revenue growth","length":122,"tagName":"p","attribs":{}},{"type":"text","content":"Dario's multi-condition digital health solutions deliver real-time results for prediabetes, diabetes, and hypertension resulting in a 23% reduction in hospitalizations, 9% reduction in healthcare utilization, and $5,000 reduction in employer costs per user","length":260,"tagName":"p","attribs":{}},{"type":"text","content":"80% of the new accounts signed in 2025 are for multi-condition programs","length":71,"tagName":"p","attribs":{}},{"type":"text","content":"Pipeline of commercial opportunities increases to $67 million","length":61,"tagName":"p","attribs":{}},{"type":"text","content":"NEW YORK, Sept. 2, 2025 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, today announced the launch of five new contracts with self-insured employers. All five programs went live during the second and third quarters of 2025 and feature Dario's full cardiometabolic suite, highlighting continued demand for integrated, multi-condition solutions.","length":452,"tagName":"p"},{"type":"image","alt":"DarioHealth Logo","displaySize":"","headline":null,"caption":"DarioHealth Logo","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":351,"url":"https://media.zenfs.com/en/prnewswire.com/aeba40a2dbbcfe9e74c653d4eb6528da"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/ARomhhCf.qvSHdwl6r9xhw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTYxOTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/aeba40a2dbbcfe9e74c653d4eb6528da","width":400,"height":351}}},{"type":"text","content":""We believe that employer contracts continue to be a powerful driver of near-term growth for Dario," said Steven Nelson, Dario's President and Chief Commercial Officer. "Building on previously announced wins and these five recent employer contracts, and supported by our robust $67 million pipeline of opportunities across employers, health plans, and pharmaceutical clients, we remain confident in our ability to reach approximately 40 new client signings by year-end 2025—a 35% increase over 2024 and a meaningful milestone on our path to profitabi...